Heart HealthOne Blood Sample Can Predict Mortality Risk Decades Early Using NMR Analysis
Nuclear magnetic resonance (NMR) blood testing goes far beyond standard cholesterol panels. In this deep-dive conversation, Peter Attia hosts physicist-turned-diagnostician Jim Otvos, who explains how NMR technology — originally developed from a flawed cancer test — can measure lipoprotein particle number, detect insulin resistance before glucose rises, and assess systemic inflammation through a marker called GlycA. The centerpiece of the episode is the Metabolic Vulnerability Index (MVX), a composite NMR-derived score that integrates markers of inflammation, malnutrition, and muscle wasting to predict mortality risk. Remarkably, MVX may flag metabolic frailty and premature mortality risk in apparently healthy young adults decades before clinical symptoms appear, offering a powerful early-warning tool for longevity-focused medicine.
